-
When fines are levied and paid, do the doctors or patients ever see anything returned? This is pretty calculated risk management on the given example below when they man had to pay over $1200 out of his own pocket for an MRI, no standard and customary corrupted data base said only $419 was allowed...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
02-15-2010
Filed under:
Filed under: Medically Related, healthcare, Claims, Blue Cross, Fraud, Lawsuits, Algorithms, Ingenix, healthcare reform, interview, billing, out of network
-
If you have kept up with the news of late, you may have read quite a bit about this issue and where the disputes lie. It all goes back to the women's health initiative and the fact that ghostwriting was used to promote the drug. Under the related reading section below I have a few posts...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-17-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Wyeth, Pfizer, Lawsuits, HRT, Insurance companies, Premarin, Women's Health Initiative, ghostwriters, Dr. Erika Schwartz, Bioidentical HRT, menopause
-
I posted this last October in 2008 and little did I know how true it would really play out to be as time moved on, those 2 items right there are what seems to make the dollars and profits in healthcare today. The DOJ certainly has been helped with the efforts of whistle blowers and there’s money...
-
We all had the bail out take place and the banks appear to be running everything. With money for healthcare at the top of the heap, there’s certainly reason to ask questions as to where the money is going, especially with the big banks making all kinds of money, using new technologies, and yet...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-24-2009
Filed under:
Filed under: Medically Related, Other Items of Interest, healthcare, Economy, Politics, Wall Street, Banking, Lawsuits, Algorithms, Audit Trails, Bloomberg, healthcare reform, banking executives, Federal Reserve, taxpayers
-
Wyeth is claiming there are 2 different versions and the generic would not be the latest version manufactured by the generic company Orchid, which would endanger patients with not receiving enough medication to clear infections. There was a case not too long ago where the generic company had issues...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-23-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, FDA, Generic Drugs, Wyeth, HHS, Pfizer, Antibiotics, Lawsuits, Orchid, Zosyn
-
This battle pretty much relates to speech as used on BlackBerries and Mobile Cell phones. The company is switching speech engines and has a battle ongoing with Nuance, who maintains the current speech engine developed by IBM and is now exploring the engine from AT&T. BD Vlingo , the Cambridge...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-17-2009
Filed under:
Filed under: Medically Related, Technology, BlackBerry, Nuance, Speech Recognition, Lawsuits, IBM, AT&T, legal battles, Vlingo, mobile technology
-
It still keeps happening and making the news. According to the story, the chart was clearly marked that it was the left and the right kidney was the one to be removed. This brings back the question once more of the “time out” and if that procedure was followed. The doctor named also...
-
Depressed cheer leaders, that one sounds like right out of the OC. Look at the one comment below, “targeted doctors would see 2 or 3 different Pfizer reps a day”, that is a lot, and they are out there, I see them all over and maybe a bit of duplicated effort, but they all seem to bring lunch! ...
-
New York is now investigating if the company sold policies without the assets to cover, sound somewhat like short selling without the funds to back it doesn’t it? The hedge funds are looking at CAPCO for information and probably some money too when it comes to settling the Lehman bankruptcy, and...
-
The good news in all of this is that the judges are not buying it, thank goodness, one plans an appeal. We all worry about side effects but it still doesn’t stand up in court with hideous crimes and the suits get filed just because “they can”, a waste of taxpayer money. BD The first...
-
Legal suits are still ramped with drug companies in the court rooms, this one has to be one of the largest settlements I am aware of, over a billion dollar infringement over the patent, or aka Intellectual Property as sometimes referred to today. The two drugs in question were Humira from Abbott...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
06-30-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Prescriptions, Patents, Johnson and Johnson, Intellectual property, Lawsuits, Abbott Labs
-
The drug was not withdrawn for not working, more so due to lawsuits and side effects, depression for one. As noted below, the US is not the first market to have the product withdrawn. Perhaps Acne will be treated more with medical devices such as this one in the future that was approved by...
-
We all remember the massive dog food recalls and we have had enough of our own too with Melamine. In China they are starting to make bricks from melamine since it is so durable, not what we want kicking around inside of us. BD The Melamine Nightmare Needs to be Fixed – Business Intelligence...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
06-17-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, FDA, Recalls, dog food, contamination, Pets, Melamine, Lawsuits, bricks, Las Vegas, Chemnutra
-
With our new administration, this is getting to be real heated topic and everyone has their points. Right now with some medications not having a generic equivalent, patents are being challenged to bring a generic to market sooner. One of the oldest methods used for years has been to –re-invent...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
03-29-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Genomics, healthcare, Pharma, Generic Drugs, warfarin, NIH, Lawsuits, blood thinners, Plavix, Bristol-Myer Squibb
-
When the lawsuits start rolling in, this company is ready to handle the volume it states. When the lawsuits begin, they anticipate a large number of requests to roll in, thus they have increased the number of employees, must be news and big time business as the took the time to create a press release...